PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF MUCOLIPIDOSIS II, COMPRISING A LYSOSOMAL ENZYME AS AN ACTIVE INGREDIENT

摘要

The present invention relates to a pharmaceutical composition comprising a lysosomal enzyme as an active ingredient for preventing or treating mucolipidosis II, wherein the lysosomal enzyme is derived from human placenta. The composition improves clinical findings of mucolipidosis II, and thus can be valuably used for preventing or treating mucolipidosis II.